LOS ANGELES--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals, Inc. (“KYTHERA”) is scheduled to present at the 29th Annual J.P. Morgan Healthcare Conference at 2:00 p.m. PST on Tuesday, January 11, 2011 at the Westin St. Francis Hotel in San Francisco, California. Keith Leonard, KYTHERA’s President and CEO, will be presenting on behalf of KYTHERA and is expected to discuss KYTHERA’s corporate strategy and provide updates on the clinical progress of the company’s lead product candidate, ATX-101, a first-in-class injectable drug being studied for the reduction of submental (under chin) fat.
